--IMAPAC had the opportunity to sit down with Rebecca Lim (Director of Scientific Affairs, Prescient Therapeutics, Australia) to discuss the cell therapy industry's latest research & development, technologies and commercialization hurdles. 00:00 Introducing Rebecca Lim01:35 Q: Could you tell me more about your company, Prescient Therapeutics?02:05 Q: In your opinion, what are the key trends that you believe will shape the gene therapy industry moving forward in a post-pandemic world, especially in Asia? 03:48 Q: Are there any exciting technologies or developments that have caught your attention in the Year 2020/2021? 05:16 Q: What are the key challenges this industry faces and is currently trying to overcome?07:00 Q: How can regulations evolve to address these challenges?08:15 Q: What are the current struggles with respect to commercialization of gene therapies and how would you suggest they be overcome? 09:30 Q: What developments should the industry look out for from Prescient Therapeutics in the coming year? 10:55 Q: Name 2 things you are looking forward to at the Cell & Gene Therapy World Asia 2021 conference. 12:00 Q: What are some of the key takeaways the audience can expect from your presentation? She will also be presenting at the upcoming 5th Annual Cell & Gene Therapy World Asia, live streaming on 15th and 16th September 2021.Join her and many cell & gene therapy experts from around the world to discuss key themes surrounding CAR-T therapies, stem cell therapies, gene therapies and more. If you'd like to join the conversation, you may register here:For biopharmas & big pharmas with their own product pipelines: https://bit.ly/3ihnuQGFor CMO/CDMO/CROs and technology providers: https://bit.ly/3yl9JpL
- Forums
- ASX - By Stock
- PTX
- Ptx to 10 bag by this time next year
Ptx to 10 bag by this time next year, page-649
-
- There are more pages in this discussion • 192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.01M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 4.0¢ | $21.95K | 548.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28166 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 224042 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28166 | 0.040 |
7 | 574751 | 0.039 |
5 | 1170000 | 0.038 |
7 | 383324 | 0.037 |
2 | 575000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 224042 | 2 |
0.042 | 570000 | 3 |
0.043 | 421000 | 2 |
0.045 | 278101 | 4 |
0.046 | 39540 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online